Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel L Alkon

Showing results (51-60 of 101) with videos related to

Pageof 11
Sort By:
Pharmacological Research|June 5, 2004
Emerging targets for the pharmacology of learning and memoryMarialaura Amadio, Stefano Govoni, Daniel L Alkon, et al.
Journal of Alzheimer'S Disease : JAD|July 16, 2014
Fibroblast aggregation rate converges with validated peripheral biomarkers for Alzheimer's diseaseFlorin V Chirila, Tapan K Khan, Daniel L Alkon
Journal of Alzheimer'S Disease : JAD|February 6, 2022
Bryostatin Placebo-Controlled Trials Indicate Cognitive Restoration Above Baseline for Advanced Alzheimer's Disease in the Absence of Memantine1Richard E Thompson, Alan J Tuchman, Daniel L Alkon
Journal of Alzheimer'S Disease : JAD|August 14, 2012
Spatiotemporal complexity of fibroblast networks screens for Alzheimer's diseaseFlorin V Chirila, Tapan K Khan, Daniel L Alkon
Trends in Pharmacological Sciences|May 12, 2015
Towards universal therapeutics for memory disordersMiao-Kun Sun, Thomas J Nelson, Daniel L Alkon
Hippocampus|April 3, 2004
Hippocampal protein-protein interactions in spatial memoryThomas J Nelson, Peter S Backlund, Daniel L Alkon
Trends in Pharmacological Sciences|January 16, 2007
PKC signaling deficits: a mechanistic hypothesis for the origins of Alzheimer's diseaseDaniel L Alkon, Miao-Kun Sun, Thomas J Nelson
Journal of Cellular Physiology|June 8, 2017
Bryostatin and its synthetic analog, picolog rescue dermal fibroblasts from prolonged stress and contribute to survival and rejuvenation of human skin equivalentsTapan K Khan, Paul A Wender, Daniel L Alkon
The Journal of Biological Chemistry|October 24, 2009
Reduction of beta-amyloid levels by novel protein kinase C(epsilon) activatorsThomas J Nelson, Changhai Cui, Yuan Luo, et al.
Journal of Alzheimer'S Disease : JAD|May 2, 2018
Loss in PKC Epsilon Causes Downregulation of MnSOD and BDNF Expression in Neurons of Alzheimer's Disease HippocampusAbhik Sen, Thomas J Nelson, Daniel L Alkon, et al.
Pageof 11

Showing results (51-60 of 101) with videos related to

Sort By:
Pageof 11
Pharmacological Research|June 5, 2004
Emerging targets for the pharmacology of learning and memoryMarialaura Amadio, Stefano Govoni, Daniel L Alkon, et al.
Journal of Alzheimer'S Disease : JAD|July 16, 2014
Fibroblast aggregation rate converges with validated peripheral biomarkers for Alzheimer's diseaseFlorin V Chirila, Tapan K Khan, Daniel L Alkon
Journal of Alzheimer'S Disease : JAD|February 6, 2022
Bryostatin Placebo-Controlled Trials Indicate Cognitive Restoration Above Baseline for Advanced Alzheimer's Disease in the Absence of Memantine1Richard E Thompson, Alan J Tuchman, Daniel L Alkon
Journal of Alzheimer'S Disease : JAD|August 14, 2012
Spatiotemporal complexity of fibroblast networks screens for Alzheimer's diseaseFlorin V Chirila, Tapan K Khan, Daniel L Alkon
Trends in Pharmacological Sciences|May 12, 2015
Towards universal therapeutics for memory disordersMiao-Kun Sun, Thomas J Nelson, Daniel L Alkon
Hippocampus|April 3, 2004
Hippocampal protein-protein interactions in spatial memoryThomas J Nelson, Peter S Backlund, Daniel L Alkon
Trends in Pharmacological Sciences|January 16, 2007
PKC signaling deficits: a mechanistic hypothesis for the origins of Alzheimer's diseaseDaniel L Alkon, Miao-Kun Sun, Thomas J Nelson
Journal of Cellular Physiology|June 8, 2017
Bryostatin and its synthetic analog, picolog rescue dermal fibroblasts from prolonged stress and contribute to survival and rejuvenation of human skin equivalentsTapan K Khan, Paul A Wender, Daniel L Alkon
The Journal of Biological Chemistry|October 24, 2009
Reduction of beta-amyloid levels by novel protein kinase C(epsilon) activatorsThomas J Nelson, Changhai Cui, Yuan Luo, et al.
Journal of Alzheimer'S Disease : JAD|May 2, 2018
Loss in PKC Epsilon Causes Downregulation of MnSOD and BDNF Expression in Neurons of Alzheimer's Disease HippocampusAbhik Sen, Thomas J Nelson, Daniel L Alkon, et al.
Pageof 11